Skip to main content

Does surviving COVID-19 guarantee that you won’t get it again?

caption: After the Food and Drug Administration granted Gilead Sciences orphan drug status for its experimental drug remdesivir on Tuesday, Gilead asked that the agency rescind that status Wednesday.
Enlarge Icon
After the Food and Drug Administration granted Gilead Sciences orphan drug status for its experimental drug remdesivir on Tuesday, Gilead asked that the agency rescind that status Wednesday.
Bloomberg via Getty Images

How likely is herd immunity to save us? How can you call BS on bad coronavirus information? And how else can the government help bolster individuals, and thus the economy?

Listen to the full show by clicking the play button above, or check out one of the show’s segments below. You can also subscribe to The Record on your favorite podcast app.

Dr. Helen Chu, antiviral clinical trials

You may have heard UW Medicine Dr. Helen Chu’s name first as the doctor who correctly identified the arrival of COVID-19 on American shores. Now she’s pioneering another front of the fight against this disease: clinical trials of an antiviral drug called remdesivir.

Carl Bergstrom, COVID-19 fake news

Misinformation has been spreading almost fast as the novel coronavirus: so much so that the WHO has declared this an “infodemic.” To hear more, we spoke to University of Washington biology professor Carl Bergstrom, who studies the flow of information among organisms – including us.

Pramila Jayapal, Paycheck Guarantee Act

The one time $1200 payment from the federal government will be arriving in some people’s bank accounts this week. But United States Representative Pramila Jayapal says more is needed, in a way that supports businesses as well as individuals. Her new paycheck guarantee act would provide some of that support; she answered those and other questions.

Why you can trust KUOW